LobbyingIncubate lobbying by quarter
Incubate's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q2 2020; the issues it reports most are Health Issues.
Incubate
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2020
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2020 | $10K | 1 |
| Q3 2020 | $10K | 1 |
| Q4 2020 | $0 | 0 |
| Q1 2021 | $0 | 0 |
| Q2 2021 | $0 | 0 |
| Q3 2021 | $0 | 0 |
| Q4 2021 | $0 | 0 |
| Q1 2022 | $0 | 0 |
| Q2 2022 | $0 | 0 |
| Q3 2022 | $0 | 0 |
| Q4 2022 | $30K | 1 |
| Q1 2023 | $30K | 1 |
| Q2 2023 | $30K | 1 |
| Q3 2023 | $30K | 1 |
| Q4 2023 | $30K | 1 |
| Q1 2024 | $30K | 1 |
| Q2 2024 | $30K | 1 |
| Q3 2024 | $30K | 1 |
| Q4 2024 | $30K | 1 |
| Q1 2025 | $30K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$470K · 17 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES17 reports
- SENATE17 reports
- White House Office5 reports
- Treasury, Dept of3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Novel Strategies Prism Group | $470K | 17 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BAYLEE FINGERHUT | n/a | Q2 2026 |
| JOHN GUY | n/a | Q2 2026 |
| JAY BRETT PERRON | n/a | Q2 2025 |
| JOHN STANFORD | n/a | Q2 2024 |
| ASHLYN ROBERTS | n/a | Q3 2023 |
| OLIVIA JANE LUCANIE | n/a | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Novel Strategies Prism Group | $30K |
| 04/17for Q1 | Novel Strategies Prism Group | $30K |
| 02/03for Q4 2025 | Novel Strategies Prism Group | $30K |
| 25/10/17for Q3 2025 | Novel Strategies Prism Group | $30K |
| 25/07/17for Q2 2025 | Novel Strategies Prism Group | $30K |
| 25/04/18for Q1 2025 | Novel Strategies Prism Group | $30K |
| 25/01/17for Q4 2024 | Novel Strategies Prism Group | $30K |
| 24/10/18for Q3 2024 | Novel Strategies Prism Group | $30K |
| 24/07/17for Q2 2024 | Novel Strategies Prism Group | $30K |
| 24/04/18for Q1 2024 | Novel Strategies Prism Group | $30K |
| 24/01/19for Q4 2023 | Novel Strategies Prism Group | $30K |
| 23/10/13for Q3 2023 | Novel Strategies Prism Group | $30K |
| 23/10/13for Q3 2023 | Novel Strategies Prism Group | $30K |
| 23/07/19for Q2 2023 | Novel Strategies Prism Group | $30K |
| 23/04/19for Q1 2023 | Novel Strategies Prism Group | $30K |
| 23/03/07for Q2 2020 | Novel Strategies Prism Group | $10K |
| 23/01/20for Q4 2022 | Novel Strategies Prism Group | $30K |
| 23/01/20for Q3 2020 | Novel Strategies Prism Group | $10K |